"Créée en 1912, au cœur de Montpellier, la clinique Clémentville a su rester fidèle à la qualité des soins et à ses spécialités en chirurgie, médecine et périnatalité. Pour plus de renseignements, n'hésitez pas à consulter notre site internet."

During the past decade, Centre de Cancérologie du Grand Montpellier conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre de Cancérologie du Grand Montpellier" #1 sponsor was "UNICANCER" with 6 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Cancérologie du Grand Montpellier" #1 collaborator was "NSABP Foundation Inc" with 2 trials as a collaborator, "National Cancer Institute, France" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Artios Pharma Ltd" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Centre de Cancérologie du Grand Montpellier" are "Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Neoplasm Metastasis" (2 trials), "Prostate Cancer" (2 trials) and "Triple Negative Breast Cancer" (2 trials). Many other conditions were trialed in "Centre de Cancérologie du Grand Montpellier" in a lesser frequency.

Most popular intervention types in "Centre de Cancérologie du Grand Montpellier" are "Drug" (15 trials), "Radiation" (3 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (4 trials), "Carboplatin" (3 trials), "Anastrozole" (2 trials), "Cetuximab" (2 trials) and "Exemestane" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre de Cancérologie du Grand Montpellier" are 15 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Centre de Cancérologie du Grand Montpellier". undefined are not yet recruiting, 12 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centre de Cancérologie du Grand Montpellier, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre de Cancérologie du Grand Montpellier, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".